Your browser doesn't support javascript.
loading
Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis.
Field, Thalia S; Dizonno, Vanessa; Almekhlafi, Mohammed A; Bala, Fouzi; Alhabli, Ibrahim; Wong, Hubert; Norena, Monica; Villaluna, Maria Karina; King-Azote, Princess; Ratnaweera, Namali; Mancini, Steven; Van Gaal, Stephen C; Wilson, Laura K; Graham, Brett R; Sposato, Luciano A; Blacquiere, Dylan; Dewar, Brian M; Boulos, Mark I; Buck, Brian H; Odier, Celine; Perera, Kanjana S; Pikula, Aleksandra; Tkach, Aleksander; Medvedev, George; Canfield, Carolyn; Mortenson, W Ben; Nadeau, Janel O; Alshimemeri, Sohaila; Benavente, Oscar R; Demchuk, Andrew M; Dowlatshahi, Dar; Lanthier, Sylvain; Lee, Agnes Y Y; Mandzia, Jennifer; Suryanarayan, Deepa; Weitz, Jeffrey I; Hill, Michael D.
Affiliation
  • Field TS; Vancouver Stroke Program, Division of Neurology (T.S.F., V.D., M.K.V., P.K-A., N.R., S.M., S.C.V.G., L.K.W., O.R.B.), University of British Columbia, Canada.
  • Dizonno V; Vancouver Stroke Program, Division of Neurology (T.S.F., V.D., M.K.V., P.K-A., N.R., S.M., S.C.V.G., L.K.W., O.R.B.), University of British Columbia, Canada.
  • Almekhlafi MA; Department of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, Canada (M.A.A., F.B., I.A., A.M.D., M.D.H.).
  • Bala F; Department of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, Canada (M.A.A., F.B., I.A., A.M.D., M.D.H.).
  • Alhabli I; Department of Radiology, Tours University Hospital, France (F.B.).
  • Wong H; Department of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, Canada (M.A.A., F.B., I.A., A.M.D., M.D.H.).
  • Norena M; School of Population and Public Health, and Centre for Health Outcomes and Evaluative Sciences (H.W., M.N.), University of British Columbia, Canada.
  • Villaluna MK; School of Population and Public Health, and Centre for Health Outcomes and Evaluative Sciences (H.W., M.N.), University of British Columbia, Canada.
  • King-Azote P; Vancouver Stroke Program, Division of Neurology (T.S.F., V.D., M.K.V., P.K-A., N.R., S.M., S.C.V.G., L.K.W., O.R.B.), University of British Columbia, Canada.
  • Ratnaweera N; Vancouver Stroke Program, Division of Neurology (T.S.F., V.D., M.K.V., P.K-A., N.R., S.M., S.C.V.G., L.K.W., O.R.B.), University of British Columbia, Canada.
  • Mancini S; Vancouver Stroke Program, Division of Neurology (T.S.F., V.D., M.K.V., P.K-A., N.R., S.M., S.C.V.G., L.K.W., O.R.B.), University of British Columbia, Canada.
  • Van Gaal SC; Vancouver Stroke Program, Division of Neurology (T.S.F., V.D., M.K.V., P.K-A., N.R., S.M., S.C.V.G., L.K.W., O.R.B.), University of British Columbia, Canada.
  • Wilson LK; Vancouver Stroke Program, Division of Neurology (T.S.F., V.D., M.K.V., P.K-A., N.R., S.M., S.C.V.G., L.K.W., O.R.B.), University of British Columbia, Canada.
  • Graham BR; Vancouver Stroke Program, Division of Neurology (T.S.F., V.D., M.K.V., P.K-A., N.R., S.M., S.C.V.G., L.K.W., O.R.B.), University of British Columbia, Canada.
  • Sposato LA; Division of Neurology, University of Saskatchewan College of Medicine, Saskatoon, Canada (B.R.G.).
  • Blacquiere D; Department of Clinical Neurosciences, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada (L.A.S., J.M.).
  • Dewar BM; Ottawa Stroke Program, Ottawa Hospital Research institute, University of Ottawa, Canada (D.B., B.M.D., D.D.).
  • Boulos MI; Ottawa Stroke Program, Ottawa Hospital Research institute, University of Ottawa, Canada (D.B., B.M.D., D.D.).
  • Buck BH; Sunnybrook Research Institute, Division of Neurology (M.I.B.), University Health Network, University of Toronto, Canada.
  • Odier C; Division of Neurology, University of Alberta, Edmonton, Canada (B.H.B.).
  • Perera KS; Département de Neurosciences, Centre Hospitalier d'Université de Montréal, Université de Montréal, Canada (C.O.).
  • Pikula A; Population Health Research Institute and Division of Neurology, McMaster University, Hamilton, Canada (K.S.P.).
  • Tkach A; Krembil Brain Institute (A.P.), University Health Network, University of Toronto, Canada.
  • Medvedev G; Kelowna General Hospital, Interior Health Authority, Canada (A.T.).
  • Canfield C; Royal Columbian Hospital, Fraser Health Authority, New Westminster, Canada (G.M.).
  • Mortenson WB; Department of Family Practice, Innovation Support Unit (C.C.), University of British Columbia, Vancouver, Canada.
  • Nadeau JO; Department of Occupational Science and Occupational Therapy (W.B.M.), University of British Columbia, Vancouver, Canada.
  • Alshimemeri S; Marlborough Medical Clinic, Calgary, Canada (J.O.N.).
  • Benavente OR; Division of Neurology, King Saud University, Riyadh, Saudi Arabia (S.A.).
  • Demchuk AM; Vancouver Stroke Program, Division of Neurology (T.S.F., V.D., M.K.V., P.K-A., N.R., S.M., S.C.V.G., L.K.W., O.R.B.), University of British Columbia, Canada.
  • Dowlatshahi D; Department of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, Canada (M.A.A., F.B., I.A., A.M.D., M.D.H.).
  • Lanthier S; Ottawa Stroke Program, Ottawa Hospital Research institute, University of Ottawa, Canada (D.B., B.M.D., D.D.).
  • Lee AYY; Hôpital de Sacre-Coeur de Montréal, Département de Neurosciences, Université de Montréal, Canada (S.L.).
  • Mandzia J; Division of Hematology (A.Y.Y.L.), University of British Columbia, Vancouver, Canada.
  • Suryanarayan D; Department of Clinical Neurosciences, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada (L.A.S., J.M.).
  • Weitz JI; Division of Hematology, Cumming School of Medicine (D.S.), University of British Columbia, Vancouver, Canada.
  • Hill MD; Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Canada (J.I.W.).
Stroke ; 54(11): 2724-2736, 2023 11.
Article in En | MEDLINE | ID: mdl-37675613

Full text: 1 Database: MEDLINE Main subject: Venous Thrombosis / Venous Thromboembolism Type of study: Clinical_trials / Diagnostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Stroke Year: 2023 Type: Article Affiliation country: Canada

Full text: 1 Database: MEDLINE Main subject: Venous Thrombosis / Venous Thromboembolism Type of study: Clinical_trials / Diagnostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Stroke Year: 2023 Type: Article Affiliation country: Canada